Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Globus Medical, Inc. Class A

Stage 4 · Declining · week 5

As of Oct 22, 2026, Globus Medical is in Stage 4, the downtrend phase, now in week 5 (since Sep 18, 2026). It closed at $81.66, 15.7% below its 52-week high and below its 200-day average, which is falling.

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. More about the company

$81.66
+3.66% today
$11.0B · Large cap
Market Neutral — Building

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is GMED early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S2 21w
S2 18w
S4 20w
S2 17w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 2w → S4 18w → S1 6w → S2 5w → S3 6w → S2 21w → S3 2w → S2 18w → S3 6w → S4 20w → S1 11w → S2 17w → S3 4w → S2 2w → S3 8w → S4 6w → S1 4w → S4 5w current
Total tracked: 165 weeks across 18 stage runs.

GMED among Medical Devices25th of 141 by relative strength

All 141 →
Stocks in Medical Devices ranked by relative strength, with stage and one-month change
#StockStageRS1M
1TXGStage 2 · wk 4899−7.8%
2RCELStage 2 · wk 1398+40.8%
3BFLYStage 2 · wk 2698−26.0%
4HAEStage 2 · wk 1796+8.7%
5GKOSStage 2 · wk 2596+15.1%
6AXGNStage 3 · wk 295−15.3%
7NEOGStage 2 · wk 1495−11.7%
8BVSStage 2 · wk 1595+10.5%
…25GMEDStage 4 · wk 577+10.4%
vs 52W High
-15.7%
$60.39 lo$96.82 hi
15.7% below 52W high, ongoing decline
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 5
1w13w26w
Week 5, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
-2.6%
200 DMA: $83.83 · sloping down
In Stage 4, the stock is below its 200-day average, the hallmark of a downtrend. Stage analysis waits for that to reverse before buying.
Rel Volume
0.93x
vs 50-day avg
High volume on down days in Stage 4 confirms institutional selling. Low-volume bounces are typical. They lack real buyers and are easy to mistake for reversals.
Trend Health
↗ ⇈
Short-term trend rising gently, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+10.4%
3M
+6.8%
6M
-13.5%
YTD
-6.5%
1Y
+30.2%
Scan Membership
Breakout Watch
Latest: 2024-10-28
9 appearances in last 60 days. First seen: 2018-10-16.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S4
Wk 5 · Vol 0.93x
2026-10-21S4
Wk 5 · Vol 0.63x
2026-10-20S4
Wk 5 · Vol 1.08x
2026-10-19S4
Wk 5 · Vol 0.85x
2026-10-16S4
Wk 5 · Vol 1.31x
2026-10-15S4
Wk 4 · Vol 1.25x
2026-10-14S4
Wk 4 · Vol 0.72x
2026-10-13S4
Wk 4 · Vol 0.75x
2026-10-12S4
Wk 4 · Vol 0.75x
2026-10-09S4
Wk 4 · Vol 0.73x
2026-10-08S4
Wk 3 · Vol 1.30x
2026-10-07S4
Wk 3 · Vol 1.73x
Moving averages & range
50 DMA
$78.24
200 DMA
$83.83
52W High
$96.82
52W Low
$60.39
5D Low
$75.65
Resistance levels (recent highs)
20d High
$81.66
60d High
$88.34
120d High
$90.60
250d High
$96.82
Next resistance
+8.2%
to 60d High
P/E (TTM)
20.9
Forward 15.1
Earnings Growth (YoY)
-26.2%
Revenue +5.9%
ROE
+11.8%
Profit margin +17.0%
Dividend Yield
0.00%
P/B 2.3

Globus Medical: quick answers

What stage is Globus Medical in?

As of Oct 22, 2026, Globus Medical (GMED) is in Stage 4, the downtrend phase. It entered Stage 4 on Sep 18, 2026 and is in week 5. What the four stages mean

Is Globus Medical in an uptrend?

No. Globus Medical is in a Stage 4 downtrend. It trades 2.6% below its 200-day average, which is falling.

How far is Globus Medical from its 52-week high?

Globus Medical closed at $81.66 on Oct 22, 2026, 15.7% below its 52-week high of $96.82. Its 52-week low is $60.39.

How has Globus Medical performed over the past year?

As of Oct 22, 2026, Globus Medical is up 30.2% over the past year and down 6.5% so far in 2026.

Which sector and industry is Globus Medical in?

Globus Medical is in the Medical Devices industry, part of the Health Care sector.

About this companyHealth Care· Medical Devices

Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating, intramedullary nailing, external fixation, and compression screw technologies; hip and knee arthroplasty solutions, including modular cement and cementless hip stems, acetabular cups, femoral heads, highly cross-linked liners, partial knee systems, cruciate retaining, posterior stabilized, and revision options; spinal cord stimulation services; and neuromonitoring services, which provide onsite and remote monitoring of the neurological systems. In addition, the company offers ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative and image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cells, tissues, and cellular and tissue-based products. The company sells its products through direct and distributor sales representatives; and independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.